Epilepsy and Neurocysticercosis in Latin America: A Systematic Review and Meta-analysis

PLoS Neglected Tropical Diseases

Volumn 7, Issue 10, 2013, Pages

  Bruno, Elisa ^a,d   Bartoloni, Alessandro ^b,d   Zammarchi, Lorenzo ^b,d   Strohmeyer, Marianne ^b,d   Bartalesi, Filippo ^b,d   Bustos, Javier ^d   Santivañez, Saul ^c   Garcia, Hector H ^d   Nicoletti, Alessandra ^a,d   Bonati, Maurizio ^d   Severino, Francesca ^d   Confalonieri, Valeria ^d   Pandolfini, Chiara ^d   Bisoffi, Zeno ^d   Buonfrate, Dora ^d   Angheben, Andrea ^d   Albonico, Marco ^d   Muñoz, Jose ^d   Pool, Robert ^d   Requena Mendez, Ana ^d   Roura, Maria ^d   Hardon, Anita ^d   Pell, Christopher ^d   Chiodini, Peter ^d   Moreira, Juan ^d   Sempértegui, Roberto ^d   Anselmi, Mariella ^d   Gotuzzo, Eduardo ^d   Mena, Maria Alejandra ^d   Torrico, Faustino ^d   Lozano, Daniel ^d   Rojas, Guido Chumiray ^d   Cabrera, Teresa Hinojosa ^d   Morón, Javier Ochoa ^d   Cuellar, Ignacio Abapori ^d   Suarez, Jaime Amorós ^d   Tognoni, Gianni ^d   Caro, Carola Liendo ^d   more..

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FUNCTIONAL NEUROIMAGING; GENETIC HETEROGENEITY; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; NEUROCYSTICERCOSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; QUESTIONNAIRE; SOUTH AND CENTRAL AMERICA; SYSTEMATIC REVIEW;

EPILEPSY; HUMANS; INCIDENCE; LATIN AMERICA; NEUROCYSTICERCOSIS; PREVALENCE;

EID: 84887275949     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002480     Document Type: Article

References (56)

1. Scott RA, Lhatoo SD, Sander JW, (2001) The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ 79: 344-351.
2. de Boer HM, Mula M, Sander JW, (2008) The global burden and stigma of epilepsy. Epilepsy Behav 12: 540-546.
3. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR, (2010) Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 51: 883-890.
4. Declaration of Santiago on epilepsy in Latin America (2002) Epilepsia 43: 42.
5. Yemadje LP, Houinato D, Quet F, Druet-Cabanac M, Preux PM, (2011) Understanding the differences in prevalence of epilepsy in tropical regions. Epilepsia 52: 1376-1381.
6. Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, et al. (2011) Incidence of epilepsy: a systematic review and meta-analysis. Neurology 77: 1005-1012.
7. Burneo JG, Tellez-Zenteno J, Wiebe S, (2005) Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res 66: 63-74.
8. Leonardi M, Ustun TB, (2002) The global burden of epilepsy. Epilepsia 43 Suppl 6: 21-25.
9. Brooker S, Alexander N, Geiger S, Moyeed RA, Stander J, et al. (2006) Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol 36: 1143-1151.
10. Preux PM, Druet-Cabanac M, (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21-31.
11. Del Brutto OH, (2012) Neurocysticercosis: a review. ScientificWorldJournal 2012: 159821.
12. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, et al. (2010) A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis Nov 2;4: e870.
13. Savioli LS, Daumerie D (2010) First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Geneva: World Health Organisation;1-169.
14. Coyle CM, Mahanty S, Zunt JR, Wallin MT, Cantey PT, et al. (2012) Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 6: e1500.
15. ILAE (1993) Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia Jul-Aug;34: 592-596.
16. Meinardi H, Scott RA, Reis R, Sander JW, (2001) The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 42: 136-149.
17. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183.
18. Garcia HH, Martinez M, Gilman R, Herrera G, Tsang VC, et al. (1991) Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet 338: 549-551.
19. Rosas N, Sotelo J, Nieto D, (1986) ELISA in the diagnosis of neurocysticercosis. Arch Neurol Apr;43: 353-356.
20. Ramos-Kuri M, Montoya RM, Padilla A, Govezensky T, Díaz ML, et al. (1992) Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzymelinked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol 49: 633-636.
21. Gabriël S, Blocher J, Dorny P, Abatih EN, Schmutzhard E, et al. (2012) Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl Trop Dis 6 (10) ():: e1851.
22. Lewis S, Clarke M, (2001) Forest plots: trying to see the wood and the trees. BMJ 322: 1479-1480.
23. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
25. Placencia M, Sander JW, Shorvon SD, Ellison RH, Cascante SM, (1992) Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain 115 (Pt 3) (): 783-794.
26. Caraveo-Andagua J, Medina-Mora ME, Rascon ML, Villatoro J, Martinez-Velez A, et al. (1996) La prevalencia de los trastornos psiquiatricos en la poblacion urbana adulta en México. Salud Mental 19: 14-21.
27. Cruz ME, Schantz PM, Cruz I, Espinosa P, Preux PM, et al. (1999) Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol 28: 799-803.
28. Del Brutto OH, Santibanez R, Idrovo L, Rodriguez S, Diaz-Calderon E, et al. (2005) Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46: 583-587.
29. Medina MT, Duron RM, Martinez L, Osorio JR, Estrada AL, et al. (2005) Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia 46: 124-131.
30. Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, et al. (2005) Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 65: 229-233.
31. Diaz-Cabezas R, Ruano-Restrepo MI, Chacon-Cardona JA, Vera-Gonzalez A, (2006) [Neuroepidemiology profile of the central zone of the department of Caldas (Colombia), years 2004-2005]. Rev Neurol 43: 646-652.
32. Pradilla G, Vesga BE, Leon-Sarmiento FE, Bautista LE, Nunez LC, et al. (2002) [Neuroepidemiology in the eastern region of Colombia]. Rev Neurol 34: 1035-1043.
33. Borges MA, Barros EP, Zanetta DM, Borges AP, (2002) [Prevalence of epilepsy in Bakairi indians from Mato Grosso State, Brazil]. Arq Neuropsiquiatr 60: 80-85.
34. Noronha AL, Borges MA, Marques LH, Zanetta DM, Fernandes PT, et al. (2007) Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia 48: 880-885.
35. Placencia M, Shorvon SD, Paredes V, Bimos C, Sander JW, et al. (1992) Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain 115 (Pt 3) (): 771-782.
36. Valenca MM, Valenca LP, (2000) [Etiology of the epileptic seizures in Recife city, Brazil: study of 249 patients]. Arq Neuropsiquiatr 58: 1064-1072.
37. Schantz PM, Sarti E, Plancarte A, Wilson M, Criales JL, et al. (1994) Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 18: 879-885.
38. Gracia F, Chavarria R, Archbold C, Larreategui M, Castillo L, et al. (1990) Neurocysticercosis in Panama: preliminary epidemiologic study in the Azuero region. Am J Trop Med Hyg 42: 67-69.
39. Arruda W, Camargo N, Coelho R, (1990) Neurocysticercosis: an epidemiological survey in two small rural communities. Arq Neuropsiquiatr 48: 419-424.
40. Silva-Vergara ML, Vieira C, Castro JH, Micheletti LG, Otaño AS, et al. (1994) [Neurologic and laboratory findings in a population of an endemic area for taeniasis-cysticercosis, Lagamar, MG, Brazil (1992-1993)]. Rev Inst Med Trop Sao Paulo 36: 335-342.
41. Garcia-Noval J, Allan JC, Fletes C, Moreno E, DeMata F, et al. (1996) Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 55: 282-289.
42. Bonametti AM, Basile MA, Vaz AJ, Baldy JL, Takiguti CK, (1992) [The positivity index of the immunoenzyme reaction (ELISA) for cysticercosis in the cerebrospinal fluid (CSF) and in the serum of epilepsy patients]. Rev Inst Med Trop Sao Paulo 34: 451-458.
43. Gracia F, de Lao SL, Castillo L, Larreategui M, Archbold C, et al. (1990) Epidemiology of epilepsy in Guaymi Indians from Bocas del Toro Province, Republic of Panama. Epilepsia 31: 718-723.
44. da Mota Gomes M, (2011) Mortality from epilepsy Brazil (capitals), 1980-2007. Arq Neuropsiquiatr 69: 166-169.
45. Devilat Barros M, Rivera Gómez G, Gómez Muñoz V, Sepulveda Olmos JP, (2004) [Mortality in children with epilepsy. A clinical prospective study]. Rev Neurol Apr 1-15; 38: 607-614.
46. Millogo A, Nitiéma P, Carabin H, Boncoeur-Martel MP, Rajshekhar V, Tarnagda Z, Praet N, et al. (2012) Prevalence of neurocysticercosis among people with epilepsy in rural areas of Burkina Faso. Epilepsia Dec;53 (12) ():: 2194-202.
47. Raina SK, Razdan S, Pandita KK, Sharma R, Gupta VP, et al. (2012) Active epilepsy as indicator of neurocysticercosis in rural northwest India. Epilepsy Res Treat 2012: 802747.
48. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, et al. (2009) Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia 50: 987-993.
49. van As AD, Joubert J, (1991) Neurocysticercosis in 578 black epileptic patients. S Afr Med J Oct 5; 80 (7) ():: 327-8.
50. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J, (2006) Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology Dec 26;67 (12) ():: 2135-9.
51. Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A, (2004) Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients. Trans R Soc Trop Med Hyg 98: 478-484.
52. Quet F, Guerchet M, Pion SD, Ngoungou EB, Nicoletti A, et al. (2010) Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia 51: 830-837.
53. Forsgren L, Hauser WA, Olafsson E, Sander JW, Sillanpaa M, et al. (2005) Mortality of epilepsy in developed countries: a review. Epilepsia 46 Suppl 11: 18-27.
54. Beghi E, Leone M, Solari A, (2005) Mortality in patients with a first unprovoked seizure. Epilepsia 46 Suppl 11: 40-42.
55. Carpio A, Bharucha NE, Jallon P, Beghi E, Campostrini R, et al. (2005) Mortality of epilepsy in developing countries. Epilepsia 46 Suppl 11: 28-32.
56. Nicoletti A, Sofia V, Vitale G, Bonelli SI, Bejarano V, et al. (2009) Natural history and mortality of chronic epilepsy in an untreated population of rural Bolivia: a follow-up after 10 years. Epilepsia Oct;50: 2199-2206.